Earnings Ahead

AERI - Aerie Pharmaceuticals

15.25 0.01 0.07

Aerie Pharmaceuticals

Aerie Pharmaceuticals

About

Profile


Headquarters

North Carolina, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

AERI



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Aerie Pharmaceuticals last day of trading expected Nov. 18 as part of Alcon merger
  • Aerie Pharmaceuticals Non-GAAP EPS of -$0.27 beats by $0.16, revenue of $36.1M beats by $0.8M
  • M&A summer uptick expected to continue, expert says
  • Alcon doubles down on glaucoma with Aerie acquisition – BTIG
  • Alcon to acquire Aerie Pharmaceuticals at ~$770M, enhancing its ophthalmic pharmaceutical portfolio
  • Aerie Pharmaceuticals grants 16.9K stock options
  • Aerie Pharma rises 14% after Q2 result beat on higher glaucoma franchise sales
  • Aerie Pharmaceuticals Non-GAAP EPS of -$0.32 beats by $0.23, revenue of $33.3M beats by $0.71M
  • Aerie Pharmaceuticals Q2 2022 Earnings Preview
  • Aerie Pharmaceuticals Q2 2022 Earnings Preview
  • Aerie Pharmaceuticals begins dosing in late-stage study of AR-15512 for dry eye disease
  • Aerie Pharmaceuticals Non-GAAP EPS of -$0.66 misses by $0.01, revenue of $29.83M misses by $0.07M
  • Aerie Pharmaceuticals Q1 consensus EPS, revenue estimates up
  • Aerie Pharmaceuticals appoints new finance chief
  • Aerie swings to profits in Q4 thanks to licensing deal with Santen
  • Aerie Pharmaceuticals Non-GAAP EPS of $1.09 beats by $1.77, revenue of $114.7M beats by $83.54M
  • Aerie Pharmaceuticals appoints Gary Sternberg as medical chief
  • Aerie Pharmaceuticals Q4 2021 Earnings Preview
  • Raj Kannan joins Aerie pharmaceuticals as CEO
  • Aerie Pharmaceuticals appoints new CEO
Date Price Open High Low Vol Change ER
Aug 4 7.37 6.80
7.63
6.77
617.27K 8.38%
Aug 3 6.80 6.44
7.11
6.44
468.93K 6.58%
Aug 2 6.38 6.24
6.52
6.05
461.23K 0.16%
Aug 1 6.37 6.83
6.94
6.35
425.78K -9.13%
Jul 29 7.01 7.24
7.24
6.53
707.95K -3.84%
 
Jul 28 7.29 7.66
7.70
7.20
329.15K -4.58%
Jul 27 7.64 7.81
7.92
7.62
322.28K -2.8%
Jul 26 7.86 7.76
7.96
7.65
196.63K 0.90%
Jul 25 7.79 7.75
7.86
7.69
174.99K 0.91%
Jul 22 7.72 8.00
8.00
7.66
377.40K -2.89%
Jul 21 7.95 7.69
8.02
7.59
461.19K 2.58%
Jul 20 7.75 8.17
8.37
7.70
581.12K -4.2%
Jul 19 8.09 8.19
8.26
7.94
1.10M -0.25%
Jul 18 8.11 8.09
8.42
8.03
350.23K 1.76%
Jul 15 7.97 8.03
8.15
7.90
236.36K -0.5%
Jul 14 8.01 8.14
8.14
7.87
312.20K -3.26%
Jul 13 8.28 8.03
8.31
8.00
189.64K 0.73%
Jul 12 8.22 8.09
8.23
7.90
235.23K 2.11%
Jul 11 8.05 8.47
8.47
7.81
353.55K -5.29%
Jul 8 8.50 8.53
8.65
8.29
535.28K -0.93%
Jul 7 8.58 8.20
8.62
8.03
737.24K 3.75%
Jul 6 8.27 8.37
8.55
8.00
411.96K -2.48%
Jul 5 8.48 8.24
8.65
8.22
484.09K 1.44%